2023Q1营收增长1.6%,营业利润下滑1.8%,净利润增长19.2%,
目前市盈率20.6倍,市盈率TTM 19.7倍,和利润增速...查看全文
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-22,Chairman, CEO, Secretary,CORNWELL KEVIN L ,卖出,1095普通股, $91.01
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-16,Director,PAYNE BARBARA A ,卖出,1000普通股, $90.70
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-15,Chairman, CEO, Secretary,CORNWELL KEVIN L ,卖出,150普通股, $91.13
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-15,Director,HOYER ERNST G ,卖出,5212普通股, $89.11
$犹他医疗产品(UTMD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0000080255-18-002287 Size: 9 KB 网页链接
$犹他医疗产品(UTMD)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-14 AccNo: 0001037389-18-000064 Size: 13 KB 网页链接
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-09,Director,HOYER ERNST G ,卖出,823普通股, $88.09
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-08,Director,HOYER ERNST G ,卖出,706普通股, $88.07
$犹他医疗产品(UTMD)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-13 AccNo: 0000315066-18-001619 Size: 9 KB 网页链接
$犹他医疗产品(UTMD)$ 内部交易: 2018-02-02,Director,HOYER ERNST G ,卖出,49普通股, $91.00